Additional file 1 of Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries

Hyun Kyeong Yoo, Han Geul Byun, Flavio Caprioli, Mathurin Fumery, Laurent Peyrin-Biroulet, Subramanian Sreedhar, James Potter & Minyoung Jang
Additional file 1.
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.